Search
for
Sort by
Research 241–270 of 1000+
- Dual-continuous microneedle patch integrating transdermal delivery of pH-sensitive licorzinc MOFs and Zn2+ hydrogel sensors for treating alopecia areata
- Late‐onset alopecia areata: A retrospective study of 73 patients from Taiwan
- Specificity of anti-SSB as a diagnostic marker for the classification of systemic lupus erythematosus
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- Stereocontrolled synthesis of all eight stereoisomers of the putative anti-androgen cyoctol
- Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis
- Emerging Unconventional Therapies for Alopecia Areata
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- Female androgenetic alopecia: An update
- Intralesional betamethasone as a therapeutic option for alopecia areata
- Alopecia areata in a patient receiving infliximab
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Efficacy and safety of a new formulation kit (shampoo + lotion) containing anti‐inflammatory and antioxidant agents to treat hair loss
- Frontal fibrosing alopecia: a review of eleven patients
- Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Alopecia and hirsutism*
- Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3
- Anti-androgen therapy in dermatology: a review
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Canities Subita after Extreme Trauma Showing Positive Staining for Anti-PD-L1 Antibodies: A New Clue into Etiopathogenesis?
- Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias?
- Frontal Fibrosing Alopecia Part II: Etiopathogenesis and Management
- Alopecia areata-like patchy non-scarring alopecia as an initial presentation of systemic lupus erythematosus
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- Platelet‐rich plasma in the treatment of alopecia areata after COVID‐19 vaccination